![5-[4-(4-Cyano-1-butyn-1-yl)phenyl]-1-(2,4-dichlorophenyl)-N-(1,1-dioxido-4-thiomorpholinyl)-4-meth…](https://static.cymitquimica.com/cas-image/298997-5-4-4-cyano-1-butyn-1-yl-phenyl-1-24-dichlorophenyl-n-11-dioxido-4-thiomorpholinyl-4-methyl-1h-pyrazole-3-carboxamide.png)
CAS: 1245626-05-4 - 5-[4-(4-Cyano-1-butyn-1-yl)phenyl]-1-(2,4-dichlorophenyl)-N-(1,1-dioxido-4-thiomorpholinyl)-4-methyl-1H-pyrazole-3-carboxamide
Formula:C26H23Cl2N5O3S
InChI:InChI=1S/C26H23Cl2N5O3S/c1-18-24(26(34)31-32-13-15-37(35,36)16-14-32)30-33(23-11-10-21(27)17-22(23)28)25(18)20-8-6-19(7-9-20)5-3-2-4-12-29/h6-11,17H,2,4,13-16H2,1H3,(H,31,34)
InChI key:InChIKey=XBHQLFVDGLPBCK-UHFFFAOYSA-N
SMILES:N#CCCC#CC=1C=CC(=CC1)C2=C(C(=NN2C3=CC=C(Cl)C=C3Cl)C(=O)NN4CCS(=O)(=O)CC4)C
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AM 6545 REF: TR-A575945CAS: 1245626-05-4 | - - - | 10,949.00 € | Tue 21 Jan 25 |
 | AM 6545 REF: 3D-VZB62605CAS: 1245626-05-4 | Min. 95% | 273.00 €~1,276.00 € | Tue 21 Jan 25 |
 | AM6545 REF: TM-T22563CAS: 1245626-05-4 | 97.03% | 96.00 €~2,337.00 € | Tue 28 Jan 25 |
AM 6545
Controlled ProductCAS:1245626-05-4
Formula:
C26H23Cl2N5O3S
Color and Shape:
Neat
Molecular weight:
556.46
Ref: TR-A575945
| 250mg | 10,949.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
AM 6545
CAS:1245626-05-4
AM 6545 is a drug that acts on the CB2 receptor, which is found on …
Formula:
C26H23Cl2N5O3S
Purity:
Min. 95%
Molecular weight:
556.46 g/mol
Ref: 3D-VZB62605
| 1mg | 273.00 € | ||
| 2mg | 400.00 € | ||
| 5mg | 569.00 € | ||
| 10mg | 813.00 € | ||
| 25mg | 1,276.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
AM6545
CAS:1245626-05-4
AM6545 is a CB1 receptor antagonist used in the study of obesity and diabetes.
Formula:
C26H23Cl2N5O3S
Purity:
97.03%
Color and Shape:
Solid
Molecular weight:
556.46
Ref: TM-T22563
| 1mg | 96.00 € | ||
| 5mg | 201.00 € | ||
| 10mg | 297.00 € | ||
| 25mg | 674.00 € | ||
| 50mg | 920.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
